AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11918129 — Biomarker: Endothelin-1
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: EDN1
Study 2503295 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31290017 — Biomarker: EMD mRNA
Type: Predictive Biomarker (PRD)
Genes: EMD; EDMD; STA
Study 31290017 — Biomarker: MCAT mRNA
Type: Predictive Biomarker (PRD)
Genes: MCAT; MT
Study 23793133 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 23793133 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 23793133 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 23793133 — Biomarker: Serum triglycerides
Type: Surrogate Endpoint (SUR)
Study 23793133 — Biomarker: Serum uric acid
Type: Surrogate Endpoint (SUR)
Study 15451390 — Biomarker: Nerve growth factor
Type: Predictive Biomarker (PRD)
Genes: NGF; NGFB
Study 15451390 — Biomarker: BDNF mRNA
Type: Predictive Biomarker (PRD); Monitoring Biomarker (MOI)
Genes: BDNF
Study 29580220 — Biomarker: GAD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GAD1; GAD; GAD67
Study 26846860 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 22441774 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 18716735 — Biomarker: Thyroid stimulating hormone
Type: Safety Biomarker (SAF)
Study 10829398 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8800586 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30610038 — Biomarker: Microsatellite instability
Type: Predictive Biomarker (PRD)
Study 22102090 — Biomarker: ERAS mRNA
Type: Predictive Biomarker (PRD)
Genes: ERAS; HRAS2; HRASP
Study 22102090 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 18815843 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15902994 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 10505693 — Biomarker: Arginine vasopressin
Type: Predictive Biomarker (PRD)
Genes: AVP; ARVP; VP
Study 1752019 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 23904472 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 22484799 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 22484799 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 15821654 — Biomarker: ITGB2 mRNA
Type: Predictive Biomarker (PRD)
Genes: ITGB2; CD18; MFI7
Study 8471416 — Biomarker: TAT mRNA
Type: Predictive Biomarker (PRD)
Genes: TAT
Study 8471416 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 31448793 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26861608 — Biomarker: Phosphatase and tensin homolog
Type: Predictive Biomarker (PRD)
Genes: PTEN; MMAC1; TEP1
Study 16164886 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28109057 — Biomarker: DES mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: DES
Study 25643050 — Biomarker: Epidermal growth factor
Type: Monitoring Biomarker (MOI)
Genes: EGF
Study 17600607 — Biomarker: GGT1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GGT1; GGT
Study 17600607 — Biomarker: ASRGL1 mRNA
Type: Predictive Biomarker (PRD)
Genes: ASRGL1; ALP; CRASH
Study 12004990 — Biomarker: KCNQ1 mRNA
Type: Predictive Biomarker (PRD)
Genes: KCNQ1; KCNA8; KCNA9; KVLQT1
Study 7788955 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29158664 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19465142 — Biomarker: FEV mRNA
Type: Predictive Biomarker (PRD)
Genes: FEV; PET1
Study 9460336 — Biomarker: Neurofilament light polypeptide
Type: Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: NEFL; NF68; NFL
Study 8203993 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 8203993 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 3294814 — Biomarker: MB mRNA
Type: Predictive Biomarker (PRD)
Genes: MB
Study 24823456 — Biomarker: POMC
Type: Predictive Biomarker (PRD)
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 1888047 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 7158401 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18338980 — Biomarker: PGC mRNA
Type: Predictive Biomarker (PRD)
Genes: PGC
Study 18338980 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 18338980 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8863008 — Biomarker: Gastric inhibitory polypeptide
Type: Pharmacodynamic Biomarker (PDY)
Genes: GIP
Study 8863008 — Biomarker: LPL mRNA
Type: Predictive Biomarker (PRD)
Genes: LPL; LIPD
Study 8863008 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 1521954 — Biomarker: RPE mRNA
Type: Predictive Biomarker (PRD)
Genes: RPE; HUSSY-17
Study 29506183 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29506183 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 7652118 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24968737 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 24968737 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 30550400 — Biomarker: RPE mRNA
Type: Predictive Biomarker (PRD)
Genes: RPE; HUSSY-17
Study 21242856 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15856433 — Biomarker: Cytochrome P450 2C19
Type: Safety Biomarker (SAF)
Genes: CYP2C19
Study 15856433 — Biomarker: CYP3A4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A4; CYP3A3
Study 27382753 — Biomarker: DST mRNA
Type: Predictive Biomarker (PRD)
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 17006600 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 15609843 — Biomarker: Complement C7
Type: Monitoring Biomarker (MOI)
Genes: C7
Study 11726725 — Biomarker: Apolipoprotein E
Type: Predictive Biomarker (PRD)
Genes: APOE
Study 25966791 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 25966791 — Biomarker: Duration of severe neutropenia
Type: Surrogate Endpoint (SUR)
Study 23496322 — Biomarker: Aminopeptidase N
Type: Safety Biomarker (SAF)
Genes: ANPEP; APN; CD13; PEPN
Study 19386307 — Biomarker: APC mRNA
Type: Predictive Biomarker (PRD)
Genes: APC; DP2.5
Study 9122731 — Biomarker: Interleukin 2
Type: Safety Biomarker (SAF)
Genes: IL2
Study 7849443 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 26156797 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 8245523 — Biomarker: Neutralizing antibody
Type: Surrogate Endpoint (SUR)
Study 30142768 — Biomarker: POR mRNA
Type: Predictive Biomarker (PRD)
Genes: POR; CYPOR
Study 23057533 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study 16837126 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10906624 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 31251550 — Biomarker: LSR mRNA
Type: Predictive Biomarker (PRD)
Genes: LSR; ILDR3; LISCH
Study 17343554 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 12135309 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 12135309 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19143950 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18342502 — Biomarker: EFS mRNA
Type: Predictive Biomarker (PRD)
Genes: EFS; CASS3
Study 15386806 — Biomarker: GAD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GAD1; GAD; GAD67
Study 12010890 — Biomarker: FAP mRNA
Type: Predictive Biomarker (PRD)
Genes: FAP
Study 31742891 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29291366 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 17644552 — Biomarker: Vascular endothelial growth factor A
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: VEGFA; VEGF
Study 17644552 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 17644552 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 17644552 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 8788536 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25427182 — Biomarker: Probing pocket depth
Type: Surrogate Endpoint (SUR)
Study 11829698 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 30099096 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27638636 — Biomarker: SRI mRNA
Type: Predictive Biomarker (PRD)
Genes: SRI
Study 20010118 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 20010118 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 16175011 — Biomarker: Plasminogen activator inhibitor
Type: Safety Biomarker (SAF)
Genes: SERPINE1; PAI1; PLANH1
Study 31262489 — Biomarker: Neutrophil gelatinase-associated lipocalin
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: LCN2; HNL; NGAL
Study 31262489 — Biomarker: Interleukin 18
Type: Safety Biomarker (SAF)
Genes: IL18; IGIF; IL1F4
Study 19017277 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 16960172 — Biomarker: EPX mRNA
Type: Predictive Biomarker (PRD)
Genes: EPX; EPER; EPO; EPP
Study 15554354 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 25223482 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 25223482 — Biomarker: Pathological complete response
Type: Surrogate Endpoint (SUR)
Study 21707775 — Biomarker: MAL mRNA
Type: Predictive Biomarker (PRD)
Genes: MAL
Study 9660087 — Biomarker: IHH mRNA
Type: Predictive Biomarker (PRD)
Genes: IHH
Study 9660087 — Biomarker: TBXT mRNA
Type: Predictive Biomarker (PRD)
Genes: TBXT; T
Study 21450674 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 9328113 — Biomarker: CD28 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD28
Study 24075505 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 24075505 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 24075505 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 24075505 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 21377273 — Biomarker: TRPV1 mRNA
Type: Predictive Biomarker (PRD)
Genes: TRPV1; VR1
Study 8642852 — Biomarker: EFS mRNA
Type: Predictive Biomarker (PRD)
Genes: EFS; CASS3
Study 16629781 — Biomarker: Exhaled nitric oxide
Type: Predictive Biomarker (PRD)
Study 11028256 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 25896101 — Biomarker: 5'-AMP-activated protein kinase subunit beta-1
Type: Pharmacodynamic Biomarker (PDY)
Genes: PRKAB1; AMPK
Study 8117550 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17934527 — Biomarker: PC mRNA
Type: Predictive Biomarker (PRD)
Genes: PC
Study 11149501 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 23378299 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 23378299 — Biomarker: Cystatin C
Type: Safety Biomarker (SAF)
Genes: CST3
Study 16218171 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 9926800 — Biomarker: Pulmonary vascular resistance
Type: Surrogate Endpoint (SUR)
Study 3283172 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29731412 — Biomarker: CGAS mRNA
Type: Predictive Biomarker (PRD)
Genes: CGAS; C6orf150; MB21D1
Study 24202399 — Biomarker: Serum potassium
Type: Surrogate Endpoint (SUR)
Study 20693353 — Biomarker: Serum potassium
Type: Surrogate Endpoint (SUR)
Study 20693353 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 10491346 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 7049706 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26956032 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26956032 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 24368224 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 24368224 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 22157519 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 18000167 — Biomarker: Interleukin 2
Type: Safety Biomarker (SAF)
Genes: IL2
Study 18000167 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 15738453 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8705151 — Biomarker: Pulmonary vascular resistance
Type: Surrogate Endpoint (SUR)
Study 8705151 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10526899 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 7721406 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 7721406 — Biomarker: Endothelin-1
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: EDN1
Study 7721406 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 2259927 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 22378918 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 28697860 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 26710337 — Biomarker: CYP2C9 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP2C9; CYP2C10
Study 26710337 — Biomarker: VKORC1 mRNA
Type: Predictive Biomarker (PRD)
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study 26710337 — Biomarker: CYP4F2 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP4F2
Study 21047696 — Biomarker: Serum alkaline phosphatase
Type: Surrogate Endpoint (SUR)
Study 27702796 — Biomarker: Cervical intraepithelial neoplasia
Type: Surrogate Endpoint (SUR)
Study 31923729 — Biomarker: Erbb2 tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 17289172 — Biomarker: Natriuretic peptides A
Type: Safety Biomarker (SAF)
Genes: NPPA; ANP; PND
Study 7702382 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 31881392 — Biomarker: F3 mRNA
Type: Predictive Biomarker (PRD)
Genes: F3
Study 10679495 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 9301382 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 27783027 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 27783027 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 25876341 — Biomarker: Antithrombin-III
Type: Safety Biomarker (SAF)
Genes: SERPINC1; AT3; PRO0309
Study 21563952 — Biomarker: MMP-1
Type: Safety Biomarker (SAF)
Genes: MMP1
Study 18677972 — Biomarker: Immunoglobulin E
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 15500103 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18476954 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 12770794 — Biomarker: HFE mRNA
Type: Predictive Biomarker (PRD)
Genes: HFE; HLAH
Study 16182733 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 23360656 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 21092293 — Biomarker: ARCN1 mRNA
Type: Predictive Biomarker (PRD)
Genes: ARCN1; COPD
Study 17993594 — Biomarker: ANG mRNA
Type: Predictive Biomarker (PRD)
Genes: ANG; RNASE5
Study 27120082 — Biomarker: Neutrophil gelatinase-associated lipocalin
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: LCN2; HNL; NGAL
Study 27120082 — Biomarker: Interleukin 18
Type: Safety Biomarker (SAF)
Genes: IL18; IGIF; IL1F4
Study 20606661 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 17256746 — Biomarker: HBV DNA
Type: Monitoring Biomarker (MOI)
Study 16297506 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 16297506 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 12235448 — Biomarker: CYP1A2 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP1A2
Study 12235448 — Biomarker: Cytochrome P450 2D6
Type: Safety Biomarker (SAF)
Genes: CYP2D6; CYP2DL1
Study 12235448 — Biomarker: CYP2E1 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP2E1; CYP2E
Study 12235448 — Biomarker: CYP3A4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP3A4; CYP3A3
Study 26188786 — Biomarker: CS mRNA
Type: Predictive Biomarker (PRD)
Genes: CS
Study 23864647 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 19386071 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 19386071 — Biomarker: SELENBP1 mRNA
Type: Predictive Biomarker (PRD)
Genes: SELENBP1; SBP
Study 19386071 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27684037 — Biomarker: FH mRNA
Type: Predictive Biomarker (PRD)
Genes: FH
Study 19565475 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 19565475 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 19565475 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 20498618 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15886236 — Biomarker: POMC
Type: Predictive Biomarker (PRD)
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 15886236 — Biomarker: Complement C3
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: C3; CPAMD1
Study 12598280 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 30475777 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 30475777 — Biomarker: Procalcitonin
Type: Monitoring Biomarker (MOI)
Study 30475777 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 30475777 — Biomarker: Interleukin 8
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CXCL8; IL8
Study 17999764 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 2692315 — Biomarker: Argininosuccinate synthase
Type: Safety Biomarker (SAF)
Genes: ASS1; ASS
Study 31004141 — Biomarker: REG3A mRNA
Type: Predictive Biomarker (PRD)
Genes: REG3A; HIP; PAP; PAP1
Study 28581341 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 23495916 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8091435 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 3053207 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 22739107 — Biomarker: MSTN mRNA
Type: Predictive Biomarker (PRD)
Genes: MSTN; GDF8
Study 12168783 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study 12168783 — Biomarker: Ki-67
Type: Predictive Biomarker (PRD)
Genes: MKI67; MIB-1; PPP1R105
Study 8564096 — Biomarker: Interferon gamma
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: IFNG
Study 8564096 — Biomarker: IL4
Type: Safety Biomarker (SAF)
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 8564096 — Biomarker: Interleukin 5
Type: Predictive Biomarker (PRD)
Genes: IL5
Study 23229165 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 2468963 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16368051 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16368051 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 16368051 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 9814501 — Biomarker: RET mRNA
Type: Predictive Biomarker (PRD)
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study 11368483 — Biomarker: CP mRNA
Type: Predictive Biomarker (PRD)
Genes: CP
Study 11368483 — Biomarker: MAS1 mRNA
Type: Predictive Biomarker (PRD)
Genes: MAS1; MAS
Study 11368483 — Biomarker: PLXNB1 mRNA
Type: Predictive Biomarker (PRD)
Genes: PLXNB1; KIAA0407; PLXN5; SEP
Study 20379030 — Biomarker: SRGN mRNA
Type: Predictive Biomarker (PRD)
Genes: SRGN; PRG; PRG1
Study 16136045 — Biomarker: HDC mRNA
Type: Predictive Biomarker (PRD)
Genes: HDC
Study 16136045 — Biomarker: Interleukin 2
Type: Safety Biomarker (SAF)
Genes: IL2
Study 27115337 — Biomarker: CYP2J2 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP2J2
Study 17616452 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15812750 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 11158473 — Biomarker: Exhaled nitric oxide
Type: Predictive Biomarker (PRD)
Study 25897569 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 21447945 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10846514 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 18078958 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 2497058 — Biomarker: TRH mRNA
Type: Predictive Biomarker (PRD)
Genes: TRH
Study 14468 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 6163829 — Biomarker: DMA mRNA
Type: Predictive Biomarker (PRD)
Genes: DMA; HLA-DMA; hCG_2001572
Study 21737178 — Biomarker: Bacterial count
Type: Surrogate Endpoint (SUR)
Study 9718197 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 8110727 — Biomarker: Interleukin 2
Type: Safety Biomarker (SAF)
Genes: IL2
Study 8110727 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 23146926 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 22172779 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 19223709 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15098969 — Biomarker: Free fatty acids
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 11676995 — Biomarker: MIP mRNA
Type: Predictive Biomarker (PRD)
Genes: MIP; AQP0
Study 11676995 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)